NASDAQ:SGRY Surgery Partners (SGRY) Stock Forecast, Price & News $39.78 +1.62 (+4.25%) (As of 06/2/2023 ET) Add Compare Share Share Today's Range$39.24▼$40.5350-Day Range$31.36▼$40.3552-Week Range$20.46▼$41.80Volume925,538 shsAverage Volume630,633 shsMarket Capitalization$5.03 billionP/E RatioN/ADividend YieldN/APrice Target$43.27 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Surgery Partners MarketRank™ ForecastAnalyst RatingModerate Buy2.78 Rating ScoreUpside/Downside10.8% Upside$44.09 Price TargetShort InterestBearish7.95% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.95Based on 8 Articles This WeekInsider TradingSelling Shares$1.59 M Sold Last QuarterProj. Earnings Growth90.32%From $0.31 to $0.59 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.74 out of 5 starsMedical Sector778th out of 983 stocksGeneral Medical & Surgical Hospitals Industry5th out of 5 stocks 2.4 Analyst's Opinion Consensus RatingSurgery Partners has received a consensus rating of Buy. The company's average rating score is 2.89, and is based on 8 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $44.09, Surgery Partners has a forecasted upside of 10.8% from its current price of $39.78.Amount of Analyst CoverageSurgery Partners has only been the subject of 4 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted7.95% of the float of Surgery Partners has been sold short.Short Interest Ratio / Days to CoverSurgery Partners has a short interest ratio ("days to cover") of 7.8.Change versus previous monthShort interest in Surgery Partners has recently increased by 4.69%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldSurgery Partners does not currently pay a dividend.Dividend GrowthSurgery Partners does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SGRY. Previous Next 2.7 News and Social Media Coverage News SentimentSurgery Partners has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Surgery Partners this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for SGRY on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Surgery Partners to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Surgery Partners insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,588,564.00 in company stock.Percentage Held by InsidersOnly 3.30% of the stock of Surgery Partners is held by insiders. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Surgery Partners are expected to grow by 90.32% in the coming year, from $0.31 to $0.59 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Surgery Partners is -43.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Surgery Partners is -43.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSurgery Partners has a P/B Ratio of 1.71. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Surgery Partners (NASDAQ:SGRY) StockSurgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services. The Surgical Facility Services segment consists of the operation of ambulatory surgery centers and surgical hospitals, including anesthesia services of the company. The Ancillary Services segment operates a diagnostic laboratory and multi-specialty physician practices. The Optical Services segment involves an optical laboratory and an optical products group purchasing organization. The company was founded in 2004 and is headquartered in Brentwood, TN.Read More Receive SGRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address SGRY Stock News HeadlinesJune 2, 2023 | msn.comB of A Securities Upgrades Surgery Partners (SGRY)June 2, 2023 | msn.comSurgery Partners raised to Buy at BofA on normalizing volumesJune 2, 2023 | Behind the Markets (Ad)[BREAKING] Small Firm Wins $1 Billion Army Contract for Breakthrough "Living Software"The Washington Post Reports it's: "A revolution in warfare." The Sunday Times Reports it's: "a revolutionary power." Early investors can reap 5,633% gains as England, Germany, Japan and Australia rush to sign contracts. Get the name of the stock here >>>June 2, 2023 | americanbankingnews.comSurgery Partners (NASDAQ:SGRY) Upgraded at Bank of AmericaMay 22, 2023 | americanbankingnews.comSurgery Partners, Inc. (NASDAQ:SGRY) Receives $43.27 Consensus Target Price from AnalystsMay 21, 2023 | americanbankingnews.comSurgery Partners (NASDAQ:SGRY) Research Coverage Started at StockNews.comMay 16, 2023 | finance.yahoo.comA Look At The Fair Value Of Surgery Partners, Inc. (NASDAQ:SGRY)May 15, 2023 | americanbankingnews.comSurgery Partners (NASDAQ:SGRY) Coverage Initiated by Analysts at MizuhoJune 2, 2023 | Chaikin Analytics (Ad)Famous Wall Street Crash System Flashes REDHundreds of banks, hedge funds, and brokerages have paid $5,000 a month to access these alerts. Because when this system flashes on U.S. stocks, huge gains – and losses – can follow.May 13, 2023 | msn.comMizuho Initiates Coverage of Surgery Partners (SGRY) with Buy RecommendationMay 6, 2023 | americanbankingnews.comQ2 2023 EPS Estimates for Surgery Partners, Inc. (NASDAQ:SGRY) Cut by AnalystMay 5, 2023 | americanbankingnews.comQ3 2023 EPS Estimates for Surgery Partners, Inc. (NASDAQ:SGRY) Cut by AnalystMay 4, 2023 | finance.yahoo.comSurgery Partners, Inc. (NASDAQ:SGRY) Q1 2023 Earnings Call TranscriptMay 4, 2023 | americanbankingnews.comStockNews.com Upgrades Surgery Partners (NASDAQ:SGRY) to "Hold"May 4, 2023 | americanbankingnews.comSurgery Partners (NASDAQ:SGRY) Shares Gap Up After Analyst UpgradeMay 3, 2023 | msn.comRBC Capital Reiterates Surgery Partners (SGRY) Outperform RecommendationMay 3, 2023 | msn.comCitigroup Maintains Surgery Partners (SGRY) Buy RecommendationMay 3, 2023 | msn.comBenchmark Reiterates Surgery Partners (SGRY) Buy RecommendationMay 2, 2023 | msn.comUnusual Call Option Trade in Surgery Partners (SGRY) Worth $285.00KMay 2, 2023 | finance.yahoo.comQ1 2023 Surgery Partners Inc Earnings CallMay 2, 2023 | americanbankingnews.comSurgery Partners (NASDAQ:SGRY) Given New $47.00 Price Target at CitigroupMay 1, 2023 | finance.yahoo.comSurgery Partners (SGRY) Q1 Earnings and Revenues Beat EstimatesMay 1, 2023 | finance.yahoo.comSurgery Partners, Inc. Announces First Quarter 2023 ResultsApril 30, 2023 | markets.businessinsider.comSurgery Partners earnings: here's what Wall Street expectsApril 30, 2023 | americanbankingnews.comSurgery Partners (SGRY) Scheduled to Post Earnings on MondayApril 28, 2023 | forbes.comHow Much Does Cataract Surgery Cost?April 28, 2023 | forbes.comWhat Is LASIK Eye Surgery? Benefits, Risks And Side EffectsSee More Headlines SGRY Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SGRY Company Calendar Last Earnings5/01/2023Today6/02/2023Next Earnings (Estimated)8/01/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry General medical & surgical hospitals Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SGRY CUSIPN/A CIK1638833 Webwww.surgerypartners.com Phone(615) 234-5900Fax615-234-5998Employees12,200Year FoundedN/APrice Target and Rating Average Stock Price Forecast$44.09 High Stock Price Forecast$56.00 Low Stock Price Forecast$35.00 Forecasted Upside/Downside+7.0%Consensus RatingModerate Buy Rating Score (0-4)2.78 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)($0.92) Trailing P/E RatioN/A Forward P/E Ratio130.48 P/E GrowthN/ANet Income$-54,600,000.00 Net Margins-3.51% Pretax Margin2.52% Return on Equity0.59% Return on Assets0.23% Debt Debt-to-Equity Ratio0.86 Current Ratio1.83 Quick Ratio1.68 Sales & Book Value Annual Sales$2.54 billion Price / Sales2.01 Cash Flow$0.96 per share Price / Cash Flow42.30 Book Value$23.26 per share Price / Book1.74Miscellaneous Outstanding Shares126,480,000Free Float122,303,000Market Cap$5.12 billion OptionableOptionable Beta2.75 Key ExecutivesJ. Eric EvansChief Executive Officer & DirectorDavid T. DohertyChief Financial Officer & Executive Vice PresidentVarun GadhokChief Information Officer & Senior Vice PresidentRoxanne WomackChief Compliance Officer & Senior Vice PresidentJennifer B. BaldockSecretary, Chief Administrative Officer & EVPKey CompetitorsTenet HealthcareNYSE:THCUniversal Health ServicesNYSE:UHSVaxcyteNASDAQ:PCVXMerit Medical SystemsNASDAQ:MMSIHealthEquityNASDAQ:HQYView All CompetitorsInsiders & InstitutionsProShare Advisors LLCBought 6,055 shares on 5/26/2023Ownership: 0.005%JPMorgan Chase & Co.Bought 42,778 shares on 5/18/2023Ownership: 0.099%New York State Common Retirement FundSold 10,094 shares on 5/18/2023Ownership: 0.021%Bradley R OwensSold 7,191 sharesTotal: $261,105.21 ($36.31/share)Advisory Services Network LLCBought 4,130 shares on 5/17/2023Ownership: 0.003%View All Insider TransactionsView All Institutional Transactions SGRY Stock - Frequently Asked Questions Should I buy or sell Surgery Partners stock right now? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last twelve months. There are currently 1 hold rating and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" SGRY shares. View SGRY analyst ratings or view top-rated stocks. What is Surgery Partners' stock price forecast for 2023? 9 brokers have issued 1-year target prices for Surgery Partners' shares. Their SGRY share price forecasts range from $35.00 to $56.00. On average, they predict the company's share price to reach $44.09 in the next twelve months. This suggests a possible upside of 9.0% from the stock's current price. View analysts price targets for SGRY or view top-rated stocks among Wall Street analysts. How have SGRY shares performed in 2023? Surgery Partners' stock was trading at $27.86 at the start of the year. Since then, SGRY shares have increased by 45.2% and is now trading at $40.45. View the best growth stocks for 2023 here. When is Surgery Partners' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 1st 2023. View our SGRY earnings forecast. How were Surgery Partners' earnings last quarter? Surgery Partners, Inc. (NASDAQ:SGRY) announced its quarterly earnings results on Monday, May, 1st. The company reported $0.05 EPS for the quarter, topping the consensus estimate of ($0.04) by $0.09. The business had revenue of $666.20 million for the quarter, compared to the consensus estimate of $644.16 million. Surgery Partners had a negative net margin of 3.51% and a positive trailing twelve-month return on equity of 0.59%. What ETFs hold Surgery Partners' stock? ETFs with the largest weight of Surgery Partners (NASDAQ:SGRY) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), iShares U.S. Healthcare Providers ETF (IHF), First Trust Mid Cap Growth AlphaDEX Fund (FNY), JPMorgan Diversified Return U.S. Small Cap Equity ETF (JPSE), Inspire Small/Mid Cap ETF (ISMD), Fidelity MSCI Health Care Index ETF (FHLC), Vanguard Health Care ETF (VHT) and AI Powered Equity ETF (AIEQ). What is Eric Evans' approval rating as Surgery Partners' CEO? 7 employees have rated Surgery Partners Chief Executive Officer Eric Evans on Glassdoor.com. Eric Evans has an approval rating of 86% among the company's employees. What other stocks do shareholders of Surgery Partners own? Based on aggregate information from My MarketBeat watchlists, some companies that other Surgery Partners investors own include Sorrento Therapeutics (SRNE), Rigel Pharmaceuticals (RIGL), Ardelyx (ARDX), Glu Mobile (GLUU), Ocular Therapeutix (OCUL), Sangamo Therapeutics (SGMO), Xilinx (XLNX), Allena Pharmaceuticals (ALNA), Editas Medicine (EDIT) and Maxar Technologies (MAXR). What is Surgery Partners' stock symbol? Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY." Who are Surgery Partners' major shareholders? Surgery Partners' stock is owned by a variety of retail and institutional investors. Top institutional investors include FMR LLC (14.95%), Wellington Management Group LLP (5.49%), Clearbridge Investments LLC (4.40%), BlackRock Inc. (3.01%), State Street Corp (0.99%) and Geode Capital Management LLC (0.96%). Insiders that own company stock include Anthony Taparo, Bradley R Owens, Brent Turner, Danielle Burkhalter, David T Doherty, George Goodwin, Jason Eric Evans, Jennifer Baldock, Laura L Brocklehurst, Laura L Brocklehurst, Marissa Brittenham, Teresa Deluca, Thomas F Cowhey and Wayne S Deveydt. View institutional ownership trends. How do I buy shares of Surgery Partners? Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Surgery Partners' stock price today? One share of SGRY stock can currently be purchased for approximately $40.45. How much money does Surgery Partners make? Surgery Partners (NASDAQ:SGRY) has a market capitalization of $5.12 billion and generates $2.54 billion in revenue each year. The company earns $-54,600,000.00 in net income (profit) each year or ($0.92) on an earnings per share basis. How many employees does Surgery Partners have? The company employs 12,200 workers across the globe. How can I contact Surgery Partners? Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The official website for the company is www.surgerypartners.com. The company can be reached via phone at (615) 234-5900, via email at ir@surgerypartners.com, or via fax at 615-234-5998. This page (NASDAQ:SGRY) was last updated on 6/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surgery Partners, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.